National Comprehensive Cancer Network



Educational Events & Programs

NCCN 2012 Congress Series: Gastrointestinal Cancers™

Wednesday, November 7, 2012
8:00 AM – 5:00 PM

(Registration begins at 7:15 AM)

Searle Center
Seeley G. Mudd Building (Duke University)
10 Searle Center Drive
Durham, North Carolina 27710

Hosted by:
Duke Cancer Institute

Register Now!


Program Overview:
This congress is a full-day educational program designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Colorectal, Hepatocellular, Pancreatic, and Gastric/Esophageal Cancers. Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. This congress will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.

Intended Audience:
This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.

Register now for this program.

Agenda*:

7:15 – 8:00 AM

Registration

8:00 – 8:10 AM

Welcome
Christopher Willett, MD
Duke Cancer Institute

COLORECTAL CANCER

8:10 – 8:45 AM

Treatment of Localized Rectal Cancer
Christopher Willett, MD
Duke Cancer Institute

8:50 – 9:15 AM

Treatment of Localized Colon Cancer
John M. Skibber, MD
The University of Texas MD Anderson Cancer Center

9:20 – 9:45 AM

Adjuvant Treatment for Colorectal Cancer
Emily Chan, MD, PhD
Vanderbilt-Ingram Cancer Center

9:50 – 10:10 AM

Break

10:10 – 10:50 AM Treatment of Metastatic Colorectal Cancer

Al B. Benson III, MD (Invited)
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

10:55 – 11:15 AM

NCCN Outcomes Database: Colorectal Cancer
John M. Skibber, MD
The University of Texas MD Anderson Cancer Center

HEPATOCELLULAR CARCINOMA

11:20 AM – 12:00 PM

Screening of High-Risk Patients and Surgical Options
Bryan M. Clary, MD
Duke Cancer Institute

12:00 – 1:00 PM

Lunch

1:00 – 1:40 PM

Selection of Systemic Therapy
Fatima A. Rangwala, MD, PhD
Duke Cancer Institute

GASTRIC/ESOPHAGEAL CANCER

1:45 – 2:30 PM

Treatment of Local Disease: A Multidisciplinary Collaboration
Thomas A. D'Amico, MD
Duke Cancer Institute

Brian Czito, MD
Duke Cancer Institute

2:35 – 3:15 PM

Management of Metastatic Disease
Jaffer A. Ajani, MD (invited)
The University of Texas MD Anderson Cancer Center

3:15 – 3:30 PM

Break

PANCREATIC CANCER

3:30 – 4:10 PM

Treatment of Local Disease and Identification of High-Risk Patients
Jason B. Fleming, MD
The University of Texas MD Anderson Cancer Center

4:15 – 4:55 PM

Management of Metastatic Disease
Eileen M. O'Reilly, MD
Memorial Sloan-Kettering Cancer Center

4:55 – 5:00 PM

Closing Remarks
Thomas A. D'Amico, MD
Duke Cancer Institute

*Subject to change


Fee Information:
There is a $49 fee for this educational activity for health care providers. There is a $495 fee for industry attendees.

Accreditation Information:
This congress is approved for AMA PRA Category 1 Credit(s)™. Nursing and pharmacy (ACPE) credits are also provided for all sessions. Please view complete accreditation details for additional information.

Supporters:
This activity is supported by an educational donation provided by Amgen. This activity is supported by educational grants from Bayer HealthCare Pharmaceuticals Inc.; Lilly USA, LLC; and Pfizer.

Register now for the NCCN 2012 Congress Series: Gastrointestinal Cancers™